TRAX
First Tracks Biotherapeutics
NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY
$23.27
-1.57% today
Updated 2026-04-30
Market cap
$821.46M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.71
Dividend yield
—
52W range
$11 – $27
Volume
0.7M
First Tracks Biotherapeutics (TRAX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item |
|---|
| Revenue |
| Revenue growth (YoY) |
| Cost of revenue |
| Gross profit |
| Gross margin |
| R&D |
| SG&A |
| Operating income |
| Operating margin |
| EBITDA |
| EBITDA margin |
| EBIT |
| Interest expense |
| Income tax |
| Effective tax rate |
| Net income |
| Net income growth (YoY) |
| Profit margin |